欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号EE/H/0302/005
药品名称Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Alembic
活性成分
    • AMLODIPINE BESILATE 10.0 mg
    • Hydrochlorothiazide 25.0 mg
    • Olmesartan medoxomil 40.0 mg
剂型Film-coated tablet
上市许可持有人Alembic Pharmaceuticals Europe Limited Palazzo Pietro Stiges, 103, Strait Street, Valletta, VLT 1436,Malta
参考成员国 - 产品名称Estonia (EE)
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Alembic
互认成员国 - 产品名称
    • Germany (DE)
      Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Alembic 40 mg/10 mg/25 mg Filmtabletten
    • Spain (ES)
许可日期2020/11/12
最近更新日期2024/10/30
药物ATC编码
    • C09DX03 olmesartan medoxomil, amlodipine and hydrochlorothiazide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase